Repare Therapeutics (RPTX) Income Statement (2019 - 2025)
Income Statement report data from Jun 30, 2019 to Sep 30, 2025 for Repare Therapeutics (RPTX).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Sep 30, 2019 | Jun 30, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | |||||||||||||||||||||||||
Total Revenue | 2.22M (+79.03%) | 1.24M (-19.48%) | 1.54M (-23.76%) | 2.02M (-19.52%) | 2.51M (-13.15%) | 2.89M (-2.69%) | 2.97M (-4.50%) | 3.11M (-6.04%) | 3.31M (-5.16%) | 3.49M (+1.75%) | 3.43M (+17.06%) | 2.93M (+44.33%) | 2.03M (+275.93%) | 540K (+315.38%) | 130K (+30.00%) | 100K (+100.00%) | 50K (+25.00%) | 40K (-33.33%) | 60K (-25.00%) | 80K (-50.00%) | 160K | - | - | - | - |
Operating Expenses | |||||||||||||||||||||||||
Research And Development | 7.50M (-47.48%) | 14M (-29.55%) | 20M (-17.27%) | 25M (-13.73%) | 28M (-5.59%) | 30M (-8.77%) | 33M (-6.52%) | 35M (+7.83%) | 33M (-3.20%) | 34M (+6.16%) | 32M (+6.49%) | 30M (-4.32%) | 31M (-0.76%) | 31M (+18.97%) | 26M (-5.40%) | 28M (+10.29%) | 25M (+25.54%) | 20M (+22.35%) | 17M (+32.93%) | 12M (+23.09%) | 10M (+12.74%) | 8.95M (+3.71%) | 8.63M (+53.56%) | 5.62M (+15.88%) | 4.85M |
Selling General And Administrative | 4.55M (-24.54%) | 6.03M (-21.18%) | 7.65M (+21.43%) | 6.30M (-2.17%) | 6.44M (-22.60%) | 8.32M (-3.48%) | 8.62M (-0.35%) | 8.65M (+9.91%) | 7.87M (-9.75%) | 8.72M (+2.23%) | 8.53M (+7.43%) | 7.94M (+0.51%) | 7.90M (-0.50%) | 7.94M (-9.57%) | 8.78M (+14.92%) | 7.64M (+15.76%) | 6.60M (-2.08%) | 6.74M (+28.63%) | 5.24M (+9.17%) | 4.80M (+20.00%) | 4.00M (+18.69%) | 3.37M (+54.59%) | 2.18M (+74.40%) | 1.25M (+21.36%) | 1.03M |
Operating Expenses | 14M (-41.43%) | 24M (-24.01%) | 31M (+1.76%) | 31M (-15.73%) | 36M (-5.26%) | 38M (-7.69%) | 42M (-5.28%) | 44M (+8.21%) | 41M (-4.54%) | 43M (+5.33%) | 40M (+6.69%) | 38M (-3.37%) | 39M (-0.66%) | 39M (+11.83%) | 35M (-1.04%) | 36M (+11.42%) | 32M (+18.59%) | 27M (+23.91%) | 22M (+26.38%) | 17M (+22.14%) | 14M (+14.37%) | 12M (+13.86%) | 11M (+57.50%) | 6.87M (+16.64%) | 5.89M |
Depreciation And Amortization | - | - | 1.19M (-16.20%) | 1.42M | - | - | 500K (-66.89%) | 1.51M | - | - | 440K (-69.86%) | 1.46M | - | - | 520K (-54.78%) | 1.15M | - | - | 320K (-54.29%) | 700K | - | - | 200K | - | - |
Operating Income | |||||||||||||||||||||||||
Operating Income | 1.13M | -17.78M (-42.99%) | -31.19M (+1.76%) | -30.65M (-15.73%) | -36.37M (-2.55%) | -37.32M | 11M | -30.87M (-19.65%) | -38.42M (+213.38%) | -12.26M (-64.65%) | -34.68M (+76.67%) | -19.63M | 73M | -38.73M (+11.20%) | -34.83M (+21.23%) | -28.73M (-9.31%) | -31.68M (+18.79%) | -26.67M (+23.59%) | -21.58M (+26.35%) | -17.08M (+21.22%) | -14.09M (+14.37%) | -12.32M (+13.97%) | -10.81M (+57.35%) | -6.87M (+16.84%) | -5.88M |
Ebit | 1.13M | -17.78M (-42.99%) | -31.19M (+1.76%) | -30.65M (-15.73%) | -36.37M (-2.55%) | -37.32M | 11M | -30.87M (-19.65%) | -38.42M (+213.38%) | -12.26M (-64.65%) | -34.68M (+76.67%) | -19.63M | 73M | -38.73M (+11.20%) | -34.83M (+21.23%) | -28.73M (-9.31%) | -31.68M (+18.79%) | -26.67M (+23.59%) | -21.58M (+26.35%) | -17.08M (+21.22%) | -14.09M (+14.37%) | -12.32M (+13.97%) | -10.81M (+57.35%) | -6.87M (+16.84%) | -5.88M |
EBITDA | 3.40M | -16.50M (-45.00%) | -30.00M (-13.17%) | -34.55M (+1.86%) | -33.92M (-1.54%) | -34.45M | 11M | -36.02M (+2.39%) | -35.18M (+297.96%) | -8.84M (-74.18%) | -34.24M (+63.36%) | -20.96M | 76M | -38.06M (+10.93%) | -34.31M (+24.31%) | -27.60M (-12.66%) | -31.60M (+18.22%) | -26.73M (+25.73%) | -21.26M (+22.11%) | -17.41M (+27.64%) | -13.64M (+16.28%) | -11.73M (+10.45%) | -10.62M (+38.64%) | -7.66M (+20.82%) | -6.34M |
Other Income / Expenses | |||||||||||||||||||||||||
Interest Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -60.00K | - | - | 60K (-25.00%) | 80K (-50.00%) | 160K | - | - | - | - |
Net Interest Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -60.00K | - | - | 60K (-25.00%) | 80K (-50.00%) | 160K | - | - | - | - |
Other Non Operating Income | 90K (-92.97%) | 1.28M (-15.23%) | 1.51M (-85.30%) | 10M | -40.00K | 2.87M (-3.69%) | 2.98M (-77.16%) | 13M (+302.78%) | 3.24M (-5.26%) | 3.42M (+1.79%) | 3.36M (-43.05%) | 5.90M (+178.30%) | 2.12M (+216.42%) | 670K (+570.00%) | 100K (+42.86%) | 70K (-12.50%) | 80K | -60.00K | 30K | -440.00K | 440K (-25.42%) | 590K | -1.73M (+118.99%) | -790.00K (+75.56%) | -450.00K |
Net Income | |||||||||||||||||||||||||
Income Before Tax | 3.40M | -16.50M (-44.39%) | -29.67M (+3.49%) | -28.67M (-15.48%) | -33.92M (-1.54%) | -34.45M | 14M | -27.84M (-20.86%) | -35.18M (+297.96%) | -8.84M (-71.78%) | -31.32M (+88.33%) | -16.63M | 76M | -38.06M (+9.62%) | -34.72M (+20.98%) | -28.70M (-9.18%) | -31.60M (+18.22%) | -26.73M (+24.04%) | -21.55M (+28.12%) | -16.82M (+23.31%) | -13.64M (+16.28%) | -11.73M (-6.53%) | -12.55M (+63.84%) | -7.66M (+20.82%) | -6.34M |
Income Tax Expense | 140K (-44.00%) | 250K (-32.43%) | 370K | - | 490K (+48.48%) | 330K (-47.62%) | 630K (+231.58%) | 190K | -16.30M | 3.11M (-14.09%) | 3.62M (-75.91%) | 15M (+29960.00%) | 50K (+66.67%) | 30K (0.00%) | 30K | -410.00K (-42.25%) | -710.00K (+69.05%) | -420.00K (+200.00%) | -140.00K (-90.97%) | -1.55M | 110K (+57.14%) | 70K (+40.00%) | 50K (+66.67%) | 30K (+50.00%) | 20K |
Net Income From Continuing Operations | 3.26M | -16.74M (-44.27%) | -30.04M (+4.78%) | -28.67M (-16.68%) | -34.41M (-1.04%) | -34.77M | 13M | -28.03M (+48.46%) | -18.88M (+57.99%) | -11.95M (-65.80%) | -34.94M (+10.36%) | -31.66M | 75M | -38.09M (+9.58%) | -34.76M (+22.87%) | -28.29M (-8.42%) | -30.89M (+17.41%) | -26.31M (+22.83%) | -21.42M (+40.37%) | -15.26M (+10.98%) | -13.75M (+16.53%) | -11.80M (-6.35%) | -12.60M (+63.85%) | -7.69M (+20.91%) | -6.36M |
Net Income | 3.26M | -16.74M (-44.27%) | -30.04M (+4.78%) | -28.67M (-16.68%) | -34.41M (-1.04%) | -34.77M | 13M | -28.03M (+48.46%) | -18.88M (+57.99%) | -11.95M (-65.80%) | -34.94M (+10.36%) | -31.66M | 75M | -38.09M (+9.58%) | -34.76M (+22.87%) | -28.29M (-8.42%) | -30.89M (+17.41%) | -26.31M (+22.83%) | -21.42M (+40.37%) | -15.26M (+10.98%) | -13.75M (+16.53%) | -11.80M (-6.35%) | -12.60M (+63.85%) | -7.69M (+20.91%) | -6.36M |
Comprehensive Income Net Of Tax | 3.28M | -16.76M (-44.30%) | -30.09M (-64.46%) | -84.66M (+148.05%) | -34.13M (-1.90%) | -34.79M | 13M | -93.34M (+398.88%) | -18.71M (+54.25%) | -12.13M (-65.09%) | -34.75M (+17.92%) | -29.47M | 75M | -38.09M (+9.58%) | -34.76M (-67.49%) | -106.91M (+246.10%) | -30.89M | - | - | - | - | - | - | - | - |